SK-1403

· Sanwa Kagaku Kenkyusho Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SK-1403, covering 2019-03-15 to 2020-03-09. Get the full timeline:

Most recent: Clinical Trial Update: SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis [Phase 3]

See pricing